Bank Of New York Mellon Corp Benitec Biopharma Inc. Transaction History

Bank Of New York Mellon Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.74 - $2.29 $74 - $231	-101 Reduced 0.68%	14,831 $17,000
Q2 2021 Aug 11, 2021	SELL	$3.94 - $5.81 $10,720 - $15,809	-2,721 Reduced 15.41%	14,932 $63,000
Q1 2021 May 13, 2021	BUY	$2.59 - $9.26 $45,721 - $163,466	17,653 New	17,653 $91,000

1.42M

Ticker BNTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,809,500
Market Cap $280M
Description
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.